Top 10 Companies in the Benzoyl Metronidazole API Industry (2025): Market Leaders Powering Dermatological Therapeutics

In Business Insights
December 04, 2025


The Global Benzoyl Metronidazole API Market was valued at USD 48.2 Million in 2024 and is projected to reach USD 65.8 Million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 5.3% during the forecast period (2024–2030). This growth is primarily driven by the rising global prevalence of rosacea and other dermatological conditions, increasing demand for combination therapies, and the expansion of pharmaceutical manufacturing capabilities in emerging economies.

As the pharmaceutical industry intensifies its focus on advanced dermatological treatments, the spotlight is on the key Active Pharmaceutical Ingredient (API) manufacturers who are ensuring the quality, stability, and supply of this critical compound. In this blog, we profile the Top 10 Companies in the Benzoyl Metronidazole API Industry—a mix of established chemical synthesizers and specialized pharmaceutical ingredient suppliers shaping the future of topical therapeutics.


🔟 1. Hongyuan Pharmaceutical

Headquarters: Xinxiang, Henan, China
Key Offering: Benzoyl Metronidazole API (CP, EP, USP Grades)

Hongyuan Pharmaceutical is a leading global supplier of pharmaceutical intermediates and APIs, with Benzoyl Metronidazole being one of its flagship products. The company operates advanced synthesis facilities and maintains stringent quality control systems compliant with international regulatory standards, serving clients across Asia, Europe, and the Americas.

Quality and Innovation Initiatives:

  • Investment in continuous flow chemistry for improved process efficiency
  • Robust analytical method development and validation capabilities
  • Focus on reducing impurities and enhancing batch-to-batch consistency

Download FREE Sample Report: Benzoyl Metronidazole API Market – View in Detailed Research Report


9️⃣ 2. Shijiazhuang No.4 Pharmaceutical Co., Ltd.

Headquarters: Shijiazhuang, Hebei, China
Key Offering: High-Purity Benzoyl Metronidazole API

With decades of experience in antibiotic and antiparasitic API manufacturing, Shijiazhuang No.4 Pharmaceutical has established itself as a reliable source for Benzoyl Metronidazole. The company’s expertise in nitroimidazole chemistry allows it to produce APIs that meet the exacting specifications of global pharmaceutical companies.

Quality and Innovation Initiatives:

  • Implementation of Quality by Design (QbD) principles in manufacturing
  • Strategic partnerships with dermatological formulation developers
  • Ongoing process optimization to reduce environmental impact

8️⃣ 3. Huanggang Yinhe Aarti Pharmaceutical Co., Ltd.

Headquarters: Huanggang, Hubei, China
Key Offering: Benzoyl Metronidazole API for Topical Formulations

Huanggang Yinhe Aarti Pharmaceutical specializes in the synthesis of complex pharmaceutical compounds, with a strong focus on dermatological APIs. The company’s Benzoyl Metronidazole is widely used in creams, gels, and lotions for the treatment of inflammatory skin conditions.

Quality and Innovation Initiatives:

  • Development of customized particle size distributions for optimal bioavailability
  • Stability studies supporting long shelf-life claims
  • Expansion of GMP-certified production capacity

7️⃣ 4. Salvavidas Pharmaceutical Pvt. Ltd.

Headquarters: Mumbai, Maharashtra, India
Key Offering: Benzoyl Metronidazole API (IP, BP, USP Grades)

As a significant player in the Indian pharmaceutical landscape, Salvavidas Pharmaceutical produces high-quality Benzoyl Metronidazole API for both domestic and international markets. The company leverages India’s cost-effective manufacturing base while maintaining compliance with stringent regulatory requirements.

Quality and Innovation Initiatives:

  • Focus on cost-efficient synthesis pathways
  • Strong regulatory affairs team for seamless market approvals
  • Investment in green chemistry initiatives

Download FREE Sample Report: Benzoyl Metronidazole API Market – View in Detailed Research Report


6️⃣ 5. Zhejiang Jiuzhou Pharmaceutical Co., Ltd.

Headquarters: Taizhou, Zhejiang, China
Key Offering: Benzoyl Metronidazole and Related Nitroimidazole APIs

Zhejiang Jiuzhou Pharmaceutical has built a reputation for excellence in the production of anti-infective APIs. Their Benzoyl Metronidazole offering benefits from the company’s deep expertise in heterocyclic chemistry and its vertically integrated supply chain for key starting materials.

Quality and Innovation Initiatives:

  • Advanced purification technologies ensuring high purity levels (>99.5%)
  • Comprehensive documentation for regulatory submissions
  • Strategic focus on high-growth emerging markets

5️⃣ 6. Fuan Pharmaceutical Group Co., Ltd.

Headquarters: Fuan, Fujian, China
Key Offering: Benzoyl Metronidazole API for Generic Drug Manufacturers

Fuan Pharmaceutical Group is a diversified pharmaceutical company with a strong API division. The company supplies Benzoyl Metronidazole to numerous generic drug manufacturers worldwide, supporting the production of affordable dermatological treatments.

Quality and Innovation Initiatives:

  • Scale-up capabilities for large-volume production
  • Strong logistics network for reliable global delivery
  • Continuous improvement of environmental, health, and safety standards

4️⃣ 7. Suzhou Tianma Specialty Chemicals Co., Ltd.

Headquarters: Suzhou, Jiangsu, China
Key Offering: Specialty Grade Benzoyl Metronidazole API

Suzhou Tianma specializes in high-value specialty chemicals and pharmaceutical intermediates. Their Benzoyl Metronidazole API is known for its consistent quality and is particularly favored by manufacturers of premium dermatological products requiring stringent specifications.

Quality and Innovation Initiatives:

  • Proprietary crystallization techniques for enhanced physicochemical properties
  • Tailored specifications for specific formulation needs
  • Strong R&D focus on novel synthetic routes

3️⃣ 8. Hubei Honglin Pharmaceutical Technology Co., Ltd.

Headquarters: Wuhan, Hubei, China
Key Offering: Benzoyl Metronidazole API with Technical Support

Hubei Honglin combines API manufacturing with extensive technical support services, helping clients optimize their formulations. The company’s strong research capabilities enable it to address complex manufacturing challenges related to Benzoyl Metronidazole.

Quality and Innovation Initiatives:

  • Collaborative approach with formulation developers
  • Advanced analytical services for impurity profiling
  • Flexible manufacturing approaches for custom requirements

2️⃣ 9. Zhejiang Hisoar Pharmaceutical Co., Ltd.

Headquarters: Taizhou, Zhejiang, China
Key Offering: Benzoyl Metronidazole API and Finished Dosage Forms

As a vertically integrated pharmaceutical company, Zhejiang Hisoar offers the unique advantage of supplying both the Benzoyl Metronidazole API and finished dosage forms. This integrated approach provides valuable insights into the practical formulation challenges and requirements for the API.

Quality and Innovation Initiatives:

  • Integrated API-formulation development capabilities
  • Strong intellectual property portfolio in dermatological products
  • Global regulatory compliance expertise

1️⃣ 10. Nanjing Dorra Pharmaceutical Technology Co., Ltd.

Headquarters: Nanjing, Jiangsu, China
Key Offering: High-Purity Benzoyl Metronidazole for Research and Commercial Use

Nanjing Dorra Pharmaceutical Technology specializes in serving the research and early development market alongside commercial-scale production. The company provides Benzoyl Metronidazole API for clinical trial materials and supports pharmaceutical companies through the development lifecycle.

Quality and Innovation Initiatives:

  • Small-scale GMP production for clinical supplies
  • Strong focus on research-grade materials for formulation development
  • Agile manufacturing approach for customized projects

Get Full Report Here: Benzoyl Metronidazole API Market – View in Detailed Research Report


🔬 Outlook: The Future of Benzoyl Metronidazole API Is Precision and Personalization

The Benzoyl Metronidazole API market is undergoing a significant transformation. While standard-grade API continues to dominate volume, the industry is increasingly focused on high-purity variants, customized physical properties, and sustainable manufacturing processes.

📈 Key Trends Shaping the Market:

  • Growing demand for combination therapies incorporating Benzoyl Metronidazole with other actives
  • Increasing regulatory scrutiny on impurity profiles and genotoxic impurities
  • Shift toward continuous manufacturing processes for improved efficiency and quality
  • Expansion of pharmaceutical manufacturing in Asia-Pacific driving regional API demand

Get Full Report Here: Benzoyl Metronidazole API Market – View in Detailed Research Report

The companies listed above are not only supplying a critical pharmaceutical ingredient—they’re enabling the development of advanced dermatological treatments that improve patient outcomes worldwide.